These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2068489)

  • 21. Immunohistochemical staining patterns of benign breast biopsies by 323/A3 and Ca1 monoclonal antibodies related to epidemiological and radiological risk criteria.
    Courtney SP; Williams S; Mansel RE
    Int Surg; 1992; 77(1):55-9. PubMed ID: 1374368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Medical treatment of mastopathies at risk].
    Pons JY
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):29-32. PubMed ID: 2068482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant breast lesions that may mimic benign tumors.
    Weidner N
    Semin Diagn Pathol; 1995 Feb; 12(1):2-13. PubMed ID: 7770672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fibrocystic mastopathy and cancer of the breast. About 111 cases].
    Beyrouti MI; Beyrouti R; Khabir A; Ben Amar M; Frikha F; Dhieb N; Damak D; Abid M; Affes N; Boujelben S; Frikha M
    Tunis Med; 2006 Oct; 84(10):626-31. PubMed ID: 17193854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
    Boecker W; Buerger H; Schmitz K; Ellis IA; van Diest PJ; Sinn HP; Geradts J; Diallo R; Poremba C; Herbst H
    J Pathol; 2001 Nov; 195(4):415-21. PubMed ID: 11745672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
    Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benign breast lesions that mimic malignant tumors: analysis of five distinct lesions.
    Weidner N
    Semin Diagn Pathol; 1990 May; 7(2):90-101. PubMed ID: 2194262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up.
    Seidman JD; Ashton M; Lefkowitz M
    Cancer; 1996 Jun; 77(12):2529-37. PubMed ID: 8640702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preneoplasia of the breast.
    Böcker W
    Verh Dtsch Ges Pathol; 1997; 81():502-13. PubMed ID: 9474891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precancerous mastopathie: structural and biological considerations.
    Black MM; Kwon S
    Pathol Res Pract; 1980; 166(4):491-514. PubMed ID: 7433230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.
    Rohan TE; Negassa A; Chlebowski RT; Habel L; McTiernan A; Ginsberg M; Wassertheil-Smoller S; Page DL
    J Natl Cancer Inst; 2008 Apr; 100(8):563-71. PubMed ID: 18398105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Automated microscopic image analysis and the prognosis of preneoplasms and carcinomas of the mammary gland].
    Guski H; Hufnagl P; Freitag A; Winzer KJ
    Gegenbaurs Morphol Jahrb; 1989; 135(1):39-53. PubMed ID: 2544475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast.
    Joshi MG; Lee AK; Pedersen CA; Schnitt S; Camus MG; Hughes KS
    Mod Pathol; 1996 Jan; 9(1):57-62. PubMed ID: 8821958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The integration of diagnostic tests and the role of outpatient surgery in the management of breast disease.
    Ranieri E; D'Andrea MR; D'Alessio A; Bergomi S; Virno F
    Int Surg; 1995; 80(2):181-4. PubMed ID: 8530240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: a cohort study.
    Cui Y; Page DL; Lane DS; Rohan TE
    Breast Cancer Res Treat; 2009 Mar; 114(1):113-20. PubMed ID: 18360772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of tumor-associated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast.
    Ohuchi N; Page DL; Merino MJ; Viglione MJ; Kufe DW; Schlom J
    J Natl Cancer Inst; 1987 Jul; 79(1):109-17. PubMed ID: 3298784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Breast lesions associated with cancer of the breast. Study of 200 excision specimens].
    Vilde F; Arkwright S
    Ann Pathol; 1987; 7(4-5):279-84. PubMed ID: 3435619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathology and heredity of breast cancer in younger women.
    Marcus JN; Watson P; Page DL; Lynch HT
    J Natl Cancer Inst Monogr; 1994; (16):23-34. PubMed ID: 7999466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mastopathy associated with early breast cancer].
    Anazawa S; Ebina D; Sakamoto G; Sugano H; Hukami A; Kuno K
    Gan No Rinsho; 1985 May; Suppl():143-7. PubMed ID: 4068232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.